Free Trial

Celanese (NYSE:CE) Director Timothy Go Buys 1,039 Shares

Celanese logo with Basic Materials background

Key Points

  • Director Timothy Go of Celanese Corporation purchased 1,039 shares at an average price of $46.25, increasing his total ownership in the company by 30.78%.
  • Celanese reported quarterly earnings of $1.44 per share, exceeding analysts' expectations of $1.38, despite a 4.5% year-over-year decrease in revenue.
  • The company's stock has faced analyst downgrades, with BMO Capital Markets reducing their price objective from $55.00 to $47.00 while maintaining a "market perform" rating.
  • Five stocks we like better than Celanese.

Celanese Corporation (NYSE:CE - Get Free Report) Director Timothy Go purchased 1,039 shares of the stock in a transaction dated Monday, September 8th. The stock was acquired at an average cost of $46.25 per share, with a total value of $48,053.75. Following the transaction, the director directly owned 4,415 shares in the company, valued at approximately $204,193.75. This trade represents a 30.78% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Celanese Stock Performance

Shares of NYSE:CE traded down $1.17 during midday trading on Friday, reaching $45.70. The company's stock had a trading volume of 1,014,011 shares, compared to its average volume of 1,897,838. The company has a quick ratio of 1.22, a current ratio of 2.05 and a debt-to-equity ratio of 2.22. The firm has a market capitalization of $5.00 billion, a PE ratio of -3.08, a P/E/G ratio of 2.12 and a beta of 1.11. Celanese Corporation has a twelve month low of $36.29 and a twelve month high of $142.54. The stock has a fifty day moving average of $50.72 and a 200 day moving average of $51.16.

Celanese (NYSE:CE - Get Free Report) last announced its quarterly earnings results on Monday, August 11th. The basic materials company reported $1.44 earnings per share for the quarter, beating analysts' consensus estimates of $1.38 by $0.06. The business had revenue of $2.53 billion during the quarter, compared to analysts' expectations of $2.50 billion. Celanese had a negative net margin of 16.30% and a positive return on equity of 10.48%. The business's revenue for the quarter was down 4.5% on a year-over-year basis. During the same period last year, the business earned $2.38 earnings per share. Celanese has set its Q3 2025 guidance at 1.100-1.400 EPS. On average, equities analysts expect that Celanese Corporation will post 8.79 EPS for the current fiscal year.

Celanese Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 11th. Shareholders of record on Tuesday, July 29th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, July 29th. Celanese's payout ratio is currently -0.81%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CE. UBS Group lowered their price objective on shares of Celanese from $66.00 to $49.00 and set a "neutral" rating for the company in a research report on Tuesday, August 12th. Cfra Research upgraded Celanese to a "moderate sell" rating in a research report on Tuesday, August 12th. JPMorgan Chase & Co. dropped their price objective on Celanese from $47.00 to $40.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Robert W. Baird cut their price target on shares of Celanese from $67.00 to $50.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Finally, KeyCorp cut their price target on shares of Celanese from $77.00 to $70.00 and set an "overweight" rating for the company in a report on Wednesday, August 13th. Six analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $57.22.

View Our Latest Research Report on CE

Institutional Investors Weigh In On Celanese

Several hedge funds and other institutional investors have recently modified their holdings of CE. Federated Hermes Inc. raised its stake in shares of Celanese by 182.1% in the second quarter. Federated Hermes Inc. now owns 5,081,458 shares of the basic materials company's stock valued at $281,157,000 after purchasing an additional 3,280,109 shares in the last quarter. Turtle Creek Asset Management Inc. raised its stake in shares of Celanese by 266.7% in the fourth quarter. Turtle Creek Asset Management Inc. now owns 3,506,440 shares of the basic materials company's stock valued at $242,681,000 after purchasing an additional 2,550,334 shares in the last quarter. Norges Bank acquired a new position in shares of Celanese in the second quarter valued at $114,934,000. Price T Rowe Associates Inc. MD raised its stake in shares of Celanese by 134.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,566,226 shares of the basic materials company's stock valued at $202,455,000 after purchasing an additional 2,044,662 shares in the last quarter. Finally, Dodge & Cox raised its stake in shares of Celanese by 13.0% in the first quarter. Dodge & Cox now owns 15,391,416 shares of the basic materials company's stock valued at $873,771,000 after purchasing an additional 1,773,354 shares in the last quarter. Institutional investors and hedge funds own 98.87% of the company's stock.

Celanese Company Profile

(Get Free Report)

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.

See Also

Should You Invest $1,000 in Celanese Right Now?

Before you consider Celanese, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celanese wasn't on the list.

While Celanese currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.